An interventional study of point-of-care ultrasound (POCUS), specifically lung ultrasound (LUS) and Modified Medical Research Council (mMRC) Dyspnea scale in Fluid Overload, POCUS and Lung Ultrasound, sponsored by Indiana University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.
Sponsored by Indiana University · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 144 studies in Edema with a site in United States — 23 open to participants now, 27 under way, 4 of them phase 3. Edema · United States.
Among the 144 studies in Edema with a site in United States, this one is the 35th largest by planned enrollment of the 110 interventional ones that give a count, is one of 10 that started in 2026, is one of 52 with no phase, reaches primary completion later than 7 of the 26 other live ones, and was the 137th registered.
568 studies on the registry are indexed under Edema; 97 are open to participants now.
Browse Edema studies →23 of the 144 studies in Edema with a site in United States are open now. Recruiting first, the newest first:
St. Jude Children's Research Hospital · Sites in United States
Ages 6–21
Ambros Therapeutics, Inc. · Sites in United States
Ages 18+
University of Washington · Sites in United States
Ages 18+
Stacy Johnson · Sites in United States
Ages 18+
Ambros Therapeutics, Inc. · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 56 Edema studies recruiting now, 34 (61%) set no upper age limit and 16 (29%) stop at 75 or younger; 8 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
144 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 24 · Phase 3 16 · Phase 4 14
First in 2000; this study’s year is marked. 10 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 54 across 402 interventional studies indexed under Edema.
Median enrollment 40 across the 110 interventional studies, 61 across the 34 observational. Of the 97 that completed or were terminated, 40 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
57 of 144 have an industry lead sponsor. The 10 most frequent:
Indiana University is the lead sponsor of 991 studies on the registry; 202 are open to participants now.
Of its 150 completed or terminated interventional studies of FDA-regulated products, 118 (79%) have results posted.
Indiana University has 3 studies filed under Edema — fewer than ten, so there is no comparison to draw.
13 of the studies in Edema with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06361537Phase 3OctapharmaStudy of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks | 2026-12 |
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
| NCT07178470Indiana UniversityConcordance and Discordance in the Assessment of Volume Status in Home Dialysis Patients: A Comparison of Modified Medical Research Council Dyspnea Scale, Physical Exam, and Point of Care Ultrasound (POCUS) | 2026-11-30 |
| NCT06979726University of FloridaGator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure | 2026-11-30 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 144 studies in Edema with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Fluid overload (when the body has too much fluid), is one of the reasons why people on home dialysis need to go to the hospital. Fluid overload commonly presents as trouble breathing and leg swelling. Traditionally, doctors check for this by asking patients if they have any symptoms like leg swelling or shortness of breath and by doing a physical exam which includes listening to the lungs or looking for swelling in legs. However, a newer, safe, and non-invasive method called point-of-care ultrasound (POCUS) has become very popular. However, there is not a lot of research yet on how POCUS and LUS (lung ultrasound) specifically help home dialysis patients, including those on peritoneal dialysis or home hemodialysis. Peritoneal dialysis is a way to clean the blood by putting a special fluid into the abdomen through a small tube. The fluid uses the natural lining of the belly as a filter to remove waste and extra water. Home hemodialysis is a treatment where a machine acts like an artificial kidney to clean the blood. Patients get trained to do this themselves at home by connecting to the machine with a couple of needles, which cleans their blood of waste and extra fluid. POCUS, especially a (LUS), has been shown to be useful for dialysis patients in outpatient units.
This study will compare different 3 different methods of detecting fluid overload in adult patients with End-stage kidney disease who are receiving home dialysis: answering various survey questions, completing a physical exam, and a LUS. The study seeks to determine which of these methods is the best method to determine fluid overload.
Participants will undergo the following assessments or procedures:
Care will be taken to expose only the area being scanned. A chaperone (someone else in the room) will be present for all female patients. All male patients will be asked if they want a chaperone. If they say yes, a chaperone will be present during the ultrasound procedure. After the ultrasound, study participation is complete.
We expect the entire study from enrollment to the completion of data collection for all subjects, to last 9 months. However, each participant will complete a single study visit, which will last for approximately 30-60 minutes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This study includes only one group all of whom get the same testing
Device: point-of-care ultrasound (POCUS), specifically lung ultrasound (LUS) · Other: Modified Medical Research Council (mMRC) Dyspnea scale · Other: Physical Exam
An eight-zone scanning protocol will be used to count the number of B-lines. Patients will be assigned a score based on the B-line count and categorized as absent, mild, moderate, or severe for fluid overload
Also known as: Ultrasound device either Phillips or Butterfly
The Modified Medical Research Council (mMRC) Dyspnea scale will be administered to patients to assess patient symptoms, with scores ranging from 0 to +4.
Clinicians will perform a physical examination using standard practices to assess for signs of fluid overload, including lower extremity edema, crackles on auscultation, weight gain, and vital signs. Patients will then be categorized as hypovolemic, euvolemic, mild, moderate, or severe volume overloaded. The physicians will be blinded to the patient reported symptoms and the LUS.
Agreement between the LUS and physical exam
Researchers will measure discordance and concordance between the LUS and physical exam. A pair is concordant if the observation ranking higher on one variable also ranks higher on the second measure. The pair is discordant if the observation ranking higher on one endpoint measure and ranks lower on the other. The pair is tied if the subjects have the same classification on both measures.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Agreement between the LUS and mMRC dyspnea scale
Researchers will measure discordance and concordance between the LUS and mMRC dyspnea scale. A pair is concordant if the observation ranking higher on one variable also ranks higher on the second measure. The pair is discordant if the observation ranking higher on one endpoint measure and ranks lower on the other. The pair is tied if the subjects have the same classification on both measures.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Agreement between the physical exam and mMRc dyspnea scale.
Researchers will measure discordance and concordance between the physical exam and mMRc dyspnea scale. A pair is concordant if the observation ranking higher on one variable also ranks higher on the second measure. The pair is discordant if the observation ranking higher on one endpoint measure and ranks lower on the other. The pair is tied if the subjects have the same classification on both measures.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Correlation of mMRC dyspnea scale and blood pressure
Researchers will evaluate whether a patient's subjective symptoms (such as their level of shortness of breath) gets worse in direct proportion to the patient's blood pressure. Blood pressure will be measured using an automated machine regularly used in the dialysis clinic.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Correlation of mMRC dyspnea scale and weight
Researchers will evaluate whether a patient's subjective symptoms (such as their level of shortness of breath) gets worse in direct proportion to the patient's weight. Weight will be measured using an automated machine regularly used in the dialysis clinic.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Correlation of LUS and blood pressure
Researchers will evaluate whether ultrasound scoring gets worse in direct proportion to blood pressure (i.e., does a higher B-line count correlate with higher blood pressure). Blood pressure will be measured using an automated machine regularly used in the dialysis clinic.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Correlation of LUS and weight
Researchers will evaluate whether ultrasound scoring gets worse in direct proportion to weight (i.e., does a higher B-line count correlate with higher weight). Weight will be measured using an automated machine regularly used in the dialysis clinic.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Correlation of physical exam and blood pressure
Researchers will evaluate whether physical exam assessment of volume status gets worse in direct proportion to blood pressure (i.e., does a higher volume overload correlate with higher blood pressure). Blood pressure will be measured using an automated machine regularly used in the dialysis clinic.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Correlation of physical exam and weight
Researchers will evaluate whether physical exam assessment of volume status gets worse in direct proportion to weight (i.e., does a higher volume overload correlate with higher weight). Weight will be measured using an automated machine regularly used in the dialysis clinic.
Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed
Plan to share: Undecided
Started Jan 2026 (actual). Primary completion is estimated for Nov 2026, 10 months after the start.
Of 153 non-industry interventional studies with no phase under Edema, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 24. This study's planned 10 months is close to that.
Counting every sponsor, half of 168 studies reached it within 11 months; a quarter within 6 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.